India’s 1st Large-Scale Trial of Two New TB Vaccines Launched
On July 15, the Indian Council of Medical Research (ICMR) launched India’s first large-scale trial for two new tuberculosis (TB) vaccines. The new vaccines that are being put through the trials offer a chance to contain the accelerating spread of multi-drug resistant TB.
Key Features
- There are two vaccines being tested in the latest trial: Immuvac (also known as mycobacterium indicus pranii or MIP), which is manufactured by Cadila Pharmaceuticals in Ahmedabad.
- And VPM1002 manufactured by Serum Institute of India in Pune.
Need for New Vaccine
- There is a critical need for new TB vaccines that are more effective than the ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
News Snippets
- 1 President Droupadi Murmu Visits Slovakia
- 2 Iran and U.S. Hold Constructive Nuclear Talks in Oman
- 3 India and Nepal Strengthen Customs Cooperation
- 4 15th BRICS Agriculture Ministers Meeting in Brazil
- 5 India, US Hail Progress on New Trade Deal
- 6 Beryl, Helene, Milton, and John Retired from Hurricane Name Lists
- 7 Similipal Declared Odisha’s Second National Park
- 8 India Opens New Frontiers in Himalayan Climate Research
- 9 Rare Sighting of Juvenile Colossal Squid in South Atlantic
- 10 Record Low Snow Persistence in Hindu Kush Himalaya Region
